Marsh & McLennan Companies (MRSH) Q2 2026 Preview: EPS Est. $2.89, Reports July 21

AlphaStreet Newsdesk powered by AlphaStreet Intelligence

MRSH|EPS Est $2.89 (22 analysts)|Rev Est $7.27B|Reports 2026-07-21 BMO

Wall Street is looking for another quarter of steady growth from Marsh & McLennan Companies, Inc. (NYSE: MRSH) when the insurance broker reports second-quarter results on July 21 before market open. The consensus among 22 analysts calls for earnings of $2.89 per share on revenue of $7.27B. Estimates for EPS range from $2.83 to $2.94, while revenue projections span $7.20B to $7.32B, reflecting relatively tight agreement on the company’s near-term outlook.

Analyst sentiment has cooled modestly in recent months. The current EPS consensus of $2.89 represents a decline of 0.3% over the past 30 days from $2.90, and a more pronounced drop of 1.7% over the past 90 days from $2.94. This downward drift in estimates suggests analysts have been trimming expectations, potentially signaling caution around margin pressure, competitive dynamics in the brokerage market, or concerns about the pace of client activity and policy renewals heading into the traditionally strong mid-year period.

The year-over-year comparison points to moderate but solid growth. Consensus EPS of $2.89 would represent a 6.2% increase from the $2.72 reported in the second quarter of 2025, while the revenue estimate of $7.27B implies 4.3% growth over the prior-year figure of $6.97B. Last year’s quarter delivered adjusted net income of $1.35B and a net margin of 19.4%, establishing a high bar for profitability. The implied growth rates suggest Marsh & McLennan is maintaining its trajectory in a competitive insurance brokerage environment, though the revenue growth rate trailing the earnings growth rate could indicate operating leverage and margin expansion are contributing to the bottom-line performance.

Understanding the company’s recent momentum will be critical context for interpreting the upcoming results. Marsh & McLennan operates across four main segments: Risk and Insurance Services (including Marsh and Guy Carpenter), Consulting (Mercer), and a smaller Health and Benefits business. Investors will be watching for commentary on new business growth, client retention rates, and trends in both risk placement and consulting advisory work. The insurance brokerage business is typically characterized by steady commission revenue streams, but can be influenced by pricing cycles in the underlying insurance market, M&A activity among clients, and corporate risk appetite. Any guidance provided last quarter for Q2 performance, along with year-to-date trends in policy placements and consulting project pipelines, will frame expectations.

Marsh & McLennan’s track record on meeting or exceeding expectations will influence how the market responds to any variance from consensus. Companies in the insurance brokerage space often demonstrate relatively predictable earnings patterns given the recurring nature of commission revenue, but can surprise on either side depending on large client wins, retention rates, and the timing of consulting engagements. Investors will scrutinize not just whether the company meets the $2.89 EPS target, but also the quality of the revenue mix and any shifts in margin profile across segments.

The stock’s technical positioning heading into the report will shape risk-reward dynamics. Where shares trade relative to their 52-week range can determine whether the market has already priced in positive momentum or remains skeptical. A stock near highs may face tougher scrutiny on any guidance moderation, while shares trading at lower levels could rally on in-line results if accompanied by constructive commentary on the pipeline and pricing environment.

This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.